ProfileGDS4132 / 235051_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 34% 37% 27% 29% 30% 33% 37% 30% 39% 40% 44% 51% 45% 39% 46% 59% 42% 40% 42% 52% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10185.134334
GSM201543Muscle PCOS pioglitazone 12187.237737
GSM201544Muscle PCOS pioglitazone 16166.367627
GSM201545Muscle PCOS pioglitazone 20178.163529
GSM201829Muscle PCOS pioglitazone 23179.860730
GSM201830Muscle PCOS pioglitazon 25184.976333
GSM201831Muscle PCOS pioglitazone 27192.573137
GSM201832Muscle PCOS pioglitazone 3174.593830
GSM201833Muscle PCOS pioglitazone 4193.822239
GSM201834Muscle PCOS pioglitazone 81101.42940
GSM201835Muscle PCOS after pioglitazone 102101.90944
GSM201836Muscle PCOS after pioglitazone 122126.60551
GSM201837Muscle PCOS after pioglitazone 162102.52145
GSM201838Muscle PCOS after pioglitazone 20290.597139
GSM201839Muscle PCOS after pioglitazone 232113.50746
GSM201840Muscle PCOS after pioglitazone 252161.46859
GSM201841Muscle PCOS after pioglitazone 27294.688942
GSM201842Muscle PCOS after pioglitazone 3285.343340
GSM201843Muscle PCOS after pioglitazone 42104.23942
GSM201844Muscle PCOS after pioglitazone 82137.73252